XXVII Wherry Memorial Lecture. Steroid therapy in otolaryngology.
D000287:Administration, Topical; D000336:Aerosols; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005158:Facial Paralysis / Q000188:drug therapy; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy; D006562:Herpes Zoster / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D006967:Hypersensitivity / Q000188:drug therapy; D007279:Injections, Subcutaneous; D007759:Labyrinth Diseases / Q000188:drug therapy; D009181:Mycoses / Q000209:etiology; D009668:Nose Diseases / Q000188:drug therapy; D010038:Otorhinolaryngologic Diseases / Q000188:drug therapy*; D011537:Pruritus / Q000188:drug therapy; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy
D000336:Aerosols; D000893:Anti-Inflammatory Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists